CHAPTER VIII RISK-MITIGATION TECHNIQUES FOR OTC DERIVATIVE CONTRACTS NOT CLEARED BY A CCP
- 12(Article 11(14)(a) of Regulation (EU) No 648/2012) Timely confirmation
- 13(Article 11(14)(a) of Regulation (EU) No 648/2012) Portfolio reconciliation
- 14(Article 11(14)(a) of Regulation (EU) No 648/2012) Portfolio compression
- 15(Article 11(14)(a) of Regulation (EU) No 648/2012) Dispute resolution
- 16(Article 11(14)(b) of Regulation (EU) No 648/2012) Market conditions that prevent marking-to-market
- 17(Article 11(14)(b) of Regulation (EU) No 648/2012) Criteria for using marking-to-model
- 18(Article 11(14)(c) of Regulation (EU) No 648/2012) Details of the intragroup transaction notification to th
- 19(Article 11(14)(d) of Regulation (EU) No 648/2012) Details of the intragroup transaction notification to ES
- 20(Article 11(14)(d) of Regulation (EU) No 648/2012) Information on the intragroup exemption to be publicly d
- 21Entry into force and application
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).